![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 29, 30844-30849, July 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interacts with Retinoid X Receptor and Interferes with Agonist-induced Apoptosis*









¶**
From the
Retinoid Research, Departments of
Biology and ¶Chemistry, Allergan Inc., Irvine, California 92612 and ||Division of Immunity and Infection, University of Birmingham Medical School, Edgbaston, Birmingham B15 2TT, United Kingdom
Agonists of retinoid X receptors (RXRs), which include the natural 9-cis-retinoic acid and synthetic analogs, are potent inducers of growth arrest and apoptosis in some cancer cells. As such, they are being used in clinical trials for the treatment and prevention of solid tumors and are used to treat cutaneous T cell lymphoma. However, the molecular mechanisms that underlie the anti-cancer effects of RXR agonists remain unclear. Here, we show that a novel pro-apoptotic pathway that is induced by RXR agonist is negatively regulated by casein kinase 1
(CK1
). CK1
associates with RXR in an agonist-dependent manner and phosphorylates RXR. The ability of an RXR agonist to recruit CK1
to a complex with RXR in cells correlates inversely with its ability to inhibit growth. Remarkably, depletion of CK1
in resistant cells renders them susceptible to RXR agonist-induced growth inhibition and apoptosis. Our study shows that CK1
can promote cell survival by interfering with RXR agonist-induced apoptosis. Inhibition of CK1
may enhance the anti-cancer effects of RXR agonists.
Received for publication, April 27, 2004 , and in revised form, May 5, 2004.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence may be addressed: Allergan Inc., Retinoid Research, 2525 Dupont Dr., Irvine, CA 92612. E-mail: zhao_yi{at}allergan.com. **To whom correspondence may be addressed: Allergan Inc., Retinoid Research, 2525 Dupont Dr., Irvine, CA 92612. E-mail: chandraratna_rosh{at}allergan.com.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Xu, C. C. L. Wong, E. H. Y. Tong, S. S. M. Chung, J. R. Yates III, Y. Yin, and B. C. B. Ko Phosphorylation by Casein Kinase 1 Regulates Tonicity-induced Osmotic Response Element-binding Protein/Tonicity Enhancer-binding Protein Nucleocytoplasmic Trafficking J. Biol. Chem., June 20, 2008; 283(25): 17624 - 17634. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Pang, A. Lin, M. Holford, B. E. Enerson, B. Lu, M. P. Lawton, E. Floyd, and H. Zhao Pathway analysis using random forests classification and regression Bioinformatics, August 15, 2006; 22(16): 2028 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kattapuram, S. Yang, J. L. Maki, and J. R. Stone Protein Kinase CK1{alpha} Regulates mRNA Binding by Heterogeneous Nuclear Ribonucleoprotein C in Response to Physiologic Levels of Hydrogen Peroxide J. Biol. Chem., April 15, 2005; 280(15): 15340 - 15347. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |